Coronavirus Outbreak: All the Secrets Revealed About the Covid-19 Pandemic. A complete Rational Guide of its Evolution, Expansion, Symptoms and First Defense

Interim Considerations for Disposition of Hospitalized Patients with
Covid-19 Infection
There is currently limited information available to describe the scope of
clinical illness, the efficiency of transmission and the length of the Covid-19
infection viral shedding. On the basis of available Covid-19 knowledge and
what is known about associated corona viruses (MERS-CoV and SARS-
CoV), interim guidance for the disposition of hospitalized patients with
Covid-19 infection was established. When new information becomes
available this advice is subject to change. The following attempts to act as a
guide for the treatment of patients. All patients should be handled on a case-
by-case basis and addressed with health care providers and public health
agencies about their attitude.
For Hospitalized Patients with Confirmed Covid-19 infection:
Usually, in an Airborne Infection Isolation Room (AIIR),
hospitalized patients with confirmed Covid-19 infection should be

---

managed using Normal, Contact, and Airborne Precautions with
eye protection.
If no immediate AIIR is available, consideration should be given to
moving the patient to an AIIR facility. The patient should be cared
for in a single-person room and the door should be kept closed if
relocation is necessary or not medically acceptable. Ideally, the
space should have no exhaust, which is re-circulated within the
building without filtration of high-efficiency particulate matter
(HEPA). Healthcare staff should still use boots, mask, breathing
and eye protection and follow all other approved procedures in the
prevention and control of infections when caring for these patients.
If there are inadequate AIIRs for patients with reported Covid-19
infection, prioritization should be provided to existing AIIRs for
patients with symptoms of severe illness (e.g., people needing
ventilator assistance).
The decision to discontinue Transmission-Based Precautions for
Covid-19 hospitalized patients should be taken on a case-by-case
basis in conjunction with physicians, infection prevention and
control professionals and public health officials and should
consider the seriousness of disease, the signs and symptoms of
disease and the findings of the Covid-19 laboratory test in
respiratory 
specimens. 
Considerations 
to 
discontinue
Transmission-Based Precautions include meeting all the following:
o Relief of fever, without use of antipyretic medication or
Improvement of disease signs and symptoms o Negative results of
Covid-19 rRT-PCR examination from at least two consecutive
respiratory tracts (nasopharyngeal swab and throat swab)
specimens obtained within 24 hours*. For 2019 Novel Corona
virus (Covid-19), see Interim Guidelines for the Selection,
Treatment, and Testing of Clinical Specimens from Persons under
Investigation (PUIs). As more information becomes available,
initial guidance is based on limited knowledge and is subject to
change. In persons with chronic active cough, sputum specimens
may detect Covid-19 RNA for longer periods than the upper
respiratory tract specimens (nasopharyngeal swab and throat
swab).